Report Detail
Global Leuprolide Acetate Market Professional Survey Report 2019
- RnM3722085 |
- 03 September, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
The global Leuprolide Acetate market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Leuprolide Acetate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leuprolide Acetate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Leuprolide Acetate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Leuprolide Acetate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Intramuscular
Subcutaneous
Segment by Application
Prostate Cancer
Precocious
Uterine Fibroid
Others
Table of Contents
Executive Summary
1 Industry Overview of Leuprolide Acetate
- 1.1 Definition of Leuprolide Acetate
- 1.2 Leuprolide Acetate Segment by Type
- 1.2.1 Global Leuprolide Acetate Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Intramuscular
- 1.2.3 Subcutaneous
- 1.3 Leuprolide Acetate Segment by Applications
- 1.3.1 Global Leuprolide Acetate Consumption Comparison by Applications (2014-2025)
- 1.3.2 Prostate Cancer
- 1.3.3 Precocious
- 1.3.4 Uterine Fibroid
- 1.3.5 Others
- 1.4 Global Leuprolide Acetate Overall Market
- 1.4.1 Global Leuprolide Acetate Revenue (2014-2025)
- 1.4.2 Global Leuprolide Acetate Production (2014-2025)
- 1.4.3 North America Leuprolide Acetate Status and Prospect (2014-2025)
- 1.4.4 Europe Leuprolide Acetate Status and Prospect (2014-2025)
- 1.4.5 China Leuprolide Acetate Status and Prospect (2014-2025)
- 1.4.6 Japan Leuprolide Acetate Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Leuprolide Acetate Status and Prospect (2014-2025)
- 1.4.8 India Leuprolide Acetate Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Leuprolide Acetate
- 2.3 Manufacturing Process Analysis of Leuprolide Acetate
- 2.4 Industry Chain Structure of Leuprolide Acetate
3 Development and Manufacturing Plants Analysis of Leuprolide Acetate
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Leuprolide Acetate Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Leuprolide Acetate
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Leuprolide Acetate Production and Capacity Analysis
- 4.2 Leuprolide Acetate Revenue Analysis
- 4.3 Leuprolide Acetate Price Analysis
- 4.4 Market Concentration Degree
5 Leuprolide Acetate Regional Market Analysis
- 5.1 Leuprolide Acetate Production by Regions
- 5.1.1 Global Leuprolide Acetate Production by Regions
- 5.1.2 Global Leuprolide Acetate Revenue by Regions
- 5.2 Leuprolide Acetate Consumption by Regions
- 5.3 North America Leuprolide Acetate Market Analysis
- 5.3.1 North America Leuprolide Acetate Production
- 5.3.2 North America Leuprolide Acetate Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Leuprolide Acetate Import and Export
- 5.4 Europe Leuprolide Acetate Market Analysis
- 5.4.1 Europe Leuprolide Acetate Production
- 5.4.2 Europe Leuprolide Acetate Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Leuprolide Acetate Import and Export
- 5.5 China Leuprolide Acetate Market Analysis
- 5.5.1 China Leuprolide Acetate Production
- 5.5.2 China Leuprolide Acetate Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Leuprolide Acetate Import and Export
- 5.6 Japan Leuprolide Acetate Market Analysis
- 5.6.1 Japan Leuprolide Acetate Production
- 5.6.2 Japan Leuprolide Acetate Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Leuprolide Acetate Import and Export
- 5.7 Southeast Asia Leuprolide Acetate Market Analysis
- 5.7.1 Southeast Asia Leuprolide Acetate Production
- 5.7.2 Southeast Asia Leuprolide Acetate Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Leuprolide Acetate Import and Export
- 5.8 India Leuprolide Acetate Market Analysis
- 5.8.1 India Leuprolide Acetate Production
- 5.8.2 India Leuprolide Acetate Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Leuprolide Acetate Import and Export
6 Leuprolide Acetate Segment Market Analysis (by Type)
- 6.1 Global Leuprolide Acetate Production by Type
- 6.2 Global Leuprolide Acetate Revenue by Type
- 6.3 Leuprolide Acetate Price by Type
7 Leuprolide Acetate Segment Market Analysis (by Application)
- 7.1 Global Leuprolide Acetate Consumption by Application
- 7.2 Global Leuprolide Acetate Consumption Market Share by Application (2014-2019)
8 Leuprolide Acetate Major Manufacturers Analysis
- 8.1 Tolmar Pharmaceuticals
- 8.1.1 Tolmar Pharmaceuticals Leuprolide Acetate Production Sites and Area Served
- 8.1.2 Tolmar Pharmaceuticals Product Introduction, Application and Specification
- 8.1.3 Tolmar Pharmaceuticals Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Varian Pharmed
- 8.2.1 Varian Pharmed Leuprolide Acetate Production Sites and Area Served
- 8.2.2 Varian Pharmed Product Introduction, Application and Specification
- 8.2.3 Varian Pharmed Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Avenit
- 8.3.1 Avenit Leuprolide Acetate Production Sites and Area Served
- 8.3.2 Avenit Product Introduction, Application and Specification
- 8.3.3 Avenit Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Takeda Pharmaceutical
- 8.4.1 Takeda Pharmaceutical Leuprolide Acetate Production Sites and Area Served
- 8.4.2 Takeda Pharmaceutical Product Introduction, Application and Specification
- 8.4.3 Takeda Pharmaceutical Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Sun Pharmaceutical Industries
- 8.5.1 Sun Pharmaceutical Industries Leuprolide Acetate Production Sites and Area Served
- 8.5.2 Sun Pharmaceutical Industries Product Introduction, Application and Specification
- 8.5.3 Sun Pharmaceutical Industries Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Livzon Pharmaceutical
- 8.6.1 Livzon Pharmaceutical Leuprolide Acetate Production Sites and Area Served
- 8.6.2 Livzon Pharmaceutical Product Introduction, Application and Specification
- 8.6.3 Livzon Pharmaceutical Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Beijing Biote Pharmaceutical
- 8.7.1 Beijing Biote Pharmaceutical Leuprolide Acetate Production Sites and Area Served
- 8.7.2 Beijing Biote Pharmaceutical Product Introduction, Application and Specification
- 8.7.3 Beijing Biote Pharmaceutical Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Soho-YImIng
- 8.8.1 Soho-YImIng Leuprolide Acetate Production Sites and Area Served
- 8.8.2 Soho-YImIng Product Introduction, Application and Specification
- 8.8.3 Soho-YImIng Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 AbbVie
- 8.9.1 AbbVie Leuprolide Acetate Production Sites and Area Served
- 8.9.2 AbbVie Product Introduction, Application and Specification
- 8.9.3 AbbVie Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Sanofi
- 8.10.1 Sanofi Leuprolide Acetate Production Sites and Area Served
- 8.10.2 Sanofi Product Introduction, Application and Specification
- 8.10.3 Sanofi Leuprolide Acetate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Astellas Pharma
- 8.12 Abbott
- 8.13 Merck
- 8.14 Pfizer
9 Development Trend of Analysis of Leuprolide Acetate Market
- 9.1 Global Leuprolide Acetate Market Trend Analysis
- 9.1.1 Global Leuprolide Acetate Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Leuprolide Acetate Regional Market Trend
- 9.2.1 North America Leuprolide Acetate Forecast 2019-2025
- 9.2.2 Europe Leuprolide Acetate Forecast 2019-2025
- 9.2.3 China Leuprolide Acetate Forecast 2019-2025
- 9.2.4 Japan Leuprolide Acetate Forecast 2019-2025
- 9.2.5 Southeast Asia Leuprolide Acetate Forecast 2019-2025
- 9.2.6 India Leuprolide Acetate Forecast 2019-2025
- 9.3 Leuprolide Acetate Market Trend (Product Type)
- 9.4 Leuprolide Acetate Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Leuprolide Acetate Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Leuprolide Acetate. Industry analysis & Market Report on Leuprolide Acetate is a syndicated market report, published as Global Leuprolide Acetate Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Leuprolide Acetate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
